HYPERTENSION
Symptoms |
Questions |
Headaches, dizziness, tinnitus, blurred vision, epistaxis, chest discomfort, palpitations, nervousness, fatigue |
Does patient check blood pressure at home? What numbers are they getting? What are the highest and lowest numbers? How often are their numbers super high? |
Complications |
Any symptoms of HTN? |
HF, CAD, MI, A Fib, aortic dissection, PAD, atherosclerosis, stroke, CKD, hypertensive nephrosclerosis, retinopathy |
What medication(s) is the patient taking? Dose? How many times a day? How many days per week does the patient forget/does not have time to take their medication? |
Risk Factors |
Obesity, diabetes, smoking, excessive alcohol/caffeine, high sodium diet, physical inactivity, stress |
Labs |
CBC, creatinine, eGFR, BMP |
HYPERTENSION: MEDICATIONS
ACEIs (lisinopril, enalapril) |
Thiazide diuretics (HCTZ) |
First-line for patients with DM, renal disease, ischaemic heart disease, and HF |
Side effects: hypokalaemia, hyponatraemia, increased glucose and cholesterol |
Side effects: dry cough, hyperkalaemia |
___ |
Adverse effects: angioedema - STOP IMMEDIATELY |
___ |
ARBs (losartan, valsartan) |
Dihydropyridine CCB (amlodipine, nifedipine) |
First-line for patients with DM, renal disease, ischaemic heart disease, and HF |
Avoid in patients with HFrEF |
Side effects: hyperkalaemia |
Side effects: oedema, nausea, flushing, HA, GERD, gingival hyperplasia |
Nondihydropyridine CCB (diltiazem, verapamil) |
Beta blockers (propranolol, metoprolol) |
Side effects: bradycardia, AV block, constipation, hyperprolactinaemia (verapamil) |
Second-line therapy; used as primary drug in patients with HF, A Fib, ischaemic heart disease |
|
Side effects: bronchoconstriction with non-cardioselective beta blockers, increased TG |
Many others, but these are the main ones that you are most likely to see in clinic.
DIABETES TYPE II
Symptoms |
Questions |
Polyuria, polydipsia, polyphagia, vision changes, poor wound healing, numbness, tingling, constipation |
Does pt check their blood sugars at home? When? What are their morning numbers (before eating)? Numbers during the day? |
Labs |
Highest and lowest blood sugars? How often? Any symptomatic low blood sugars? |
A1c (every 3-6 months), BMP (renal function and electrolytes), LFTs, lipids, urine microalb/cr |
If on insulin, how many units with which type of insulin? How often do they forget/are too busy to take their insulin? |
Look For |
Numbness, tingling, etc? Vision changes? |
Statin therapy regardless, ASCVD assessment for high-intensity statin |
Have they seen an eye doctor in the past year? |
Last ophthalmology exam, podiatry |
Physical Exam |
Foot exam, acanthosis nigricans |
DIABETES TYPE II: TREATMENT
Metformin |
Sulphonylureas |
Enhances effect of insulin. Weight loss. |
Glyburide, glimepiride, glipizide |
Side effects: lactic acidosis, GI complaints (only when first starting, D/C), decreased B12 absorption |
Increase insulin secretion |
Contraindication: CKD w/ GFR <30 |
Side effects: risk of hypoglycaemia, weight gain, agranulocytosis, haemolysis |
_____ |
Contraindications: CV comorbidity, obesity, severe renal/liver failure |
SGLT-2 Inhibitors |
Meglitinides |
Canagliflozin, dapagliflozin, empagliflozin |
Nateglinide, repaglinide |
Increases glucose excretion with urine |
Increases insulin secretion |
Side effects: genital yeast infections and UTI, polyuria and dehydration, DKAContraindication: CKD, recurrent UTIs |
Side effects: risk of hypoglycaemia, weight gain |
Contraindication: CKD, recurrent UTIs |
Contraindication: severe liver failure |
DPP-4 Inhibitors |
GLP-1 Agonists |
Saxagliptin, sitagliptin |
Exenatide, liraglutide |
Inhibits GLP-1 degradation |
Stimulates GLP-1 receptors |
Side effects: GI sx, pancreatitis, URI, headache, dizziness, oedema |
Side effects: pancreatitis, possible pancreatic cancer, nausea |
Contraindication: liver failure, moderate to severe renal failure |
Contraindications: pre-existing, sx GI motility disorders |
_____ |
______ |
_____ |
______ |
Rapid Acting Insulin |
Long-Acting Insulin |
Lispro, aspart, glulisine |
Glargine, detemir, degludec |
Onset: 5-15 min, Peak: 1 hr, Duration: 3-4 hrs |
Onset: 1-4 hrs, Duration: 24 hrs |
Before meals |
Once daily |
Adverse Effects of Insulin |
Hypoglycaemia, weight gain, lipodystrophy, hypokalaemia, oedema, pain/erythema at injection site |
|
|
CORONARY ARTERY DISEASE
Symptoms |
Questions |
Angina: Retrosternal chest pain/pressure that may radiate to the L arm, neck, jaw, or back. Pain is not affected by body position or breathing. No chest wall tenderness. Dyspnea, dizziness, palpitations, diaphoresis, n/v, syncope |
Has patient had chest pain since last visit? Is it occuring more often or stable? Does nitro help relieve pain? |
Stable angina: chest pain/sx reproducible/predictable, subside with rest or nitroglycerin. |
Any hospitalisations since last visit? |
Things to Check For |
Medication compliance? |
ASCVD score, new ECGs, stress tests, ECHO, CT angio, coronary artery calcium (CAC) scoring, cardiac catheterisations |
Any of the other symptoms besides chest pain? |
Revascularisation - PCI or CABG |
If they follow with cardiology, when was the last time they were seen? |
Secondary Prevention |
Smoking cessation, increased physical activity, lifelonf antiplatelet therapy with aspiring or clopidogrel, treat comorbidities, lipid-lowering therapy |
CORONARY ARTERY DISEASE: TREATMENT
Anti-anginal Drugs |
Antiplatelet Agents |
First-line: beta-blockers |
Recommended for all patients |
Second-line: CCBs, nitrates, ranolazine |
Aspirin, clopidogrel |
ACEIs or ARBs |
Revascularisation |
In patients who also have HTN, DM, LVEF 40% or <, CKD |
CABG |
Lisinopril, ramipril. Losartan, valsartan. |
PCI |
COPD & TREATMENT
Symptoms |
Complications |
Cough, dyspnea, fatigue, hyperventilation |
Chronic respiratory failure, R HF (cor pulmonale), secondary spontaneous pneumothorax |
Physical Exam |
Treatment |
Accessory muscle use, barrel chest, decreased breath sounds, end-expiratory wheezing and/or prolonged expiration, rhonchi/crackles, cyanosis, tachycardia, JVD, oedema, nail clubbing |
Short-acting beta agonists: salbutamol |
Labs |
Long-acting beta agonists: salmeterol |
CBC |
Short-acting muscarinic antagonists: ipratropium bromide |
Things To Look For |
Long-acting muscarinic antagonists: tiotropium bromide |
PFT: FEV1 and FEV1/FVC |
Inhaled corticosteroids: budesonide, fluticasone |
CXR, chest CT |
Pulmonology clinic notes |
Questions: How often they use albuterol inhaler? Any hospitalisations due to COPD exacerbation since last visit? If on O2, when do they use it? How has their COPD been - stable, worse? Have they used their steroids (pills) since the last visit (if they have them, some have to prevent exacerbations)?
CKD
Risk Factors |
Treatment |
DMII, HTN, obesity, advanced age, substance use, AKI |
Diet |
Aetiology |
Avoidance of nephrotoxic substances: NSAIDs, antifungal, antibiotics, antivirals |
Diabetic nephropathy, hypertensive nephropathy, glomerulonephritis, PKD, analgesic misuse, amyloidosis |
Control underlying condition and comorbidities |
Labs |
Haemodialysis |
CBC, BMP (Cr, BUN), PT, PTT, bleeding time, lipid panel, blood pH, eGFR, urinalysis, urine microalb/cr |
Complications |
|
CKD-mineral and bone disorder, secondary hyperparathyroidism, anaemia, ESRD |
|
|
CONGESTIVE HEART FAILURE
Symptoms |
Lifestyle Modifications |
Nocturia, fatigue, tachycardia, dyspnea, orthopnea, PND, peripheral oedema |
Exercise, cessation of smoking/EtOH/recreational drugs, weight loss, immunisations |
Physical Exam |
Diet and fluid restriction |
S3/S4 gallop, pulsus alternans, bilateral basilar crackles, displaced apical heart beat, peripheral pitting oedema, JVD, hepatojugular reflux |
Self-monitoring and symptom recognition (if pt gains > 4-5 lbs within 3 days -> fluid overloaded) |
Labs |
Drugs to Avoid |
CBC, BMP, LFTs, lipid panel |
Most antiarrhythmic drugs, CCB (except amlodipine), NSAIDs, thiazolidinediones |
Know baseline BNP |
Look For |
Echo - ejection fraction, valvular dysfunction |
CXR - cardiac silhouette, pulmonary congestion |
ECG - LVH |
Cardiac MRI, L heart cath/angio, R heart cath |
CONGESTIVE HEART FAILURE: TREATMENT
ACEIs |
Aldosterone Antagonists |
Enalapril, lisinopril |
Spironolactone, eplerenone |
Every patient with HFrEF |
Class II-IV and LVEF <35% |
ARBs |
Monitor for hyperkalaemia |
Losartan, valsartan |
Loop Diuretics and Thiazide Diuretics |
Beta Blockers |
Loop: furosemide, torsemide |
Carvedilol, metoprolol |
Thiazide: HCTZ, metolazone, chlorthalidone |
Add once patient is stable on ACEI/ARB and no decompensated |
To treat volume overload |
CIRRHOSIS
Symptoms |
Things to Look Out For |
Often asymptomatic |
Child-Pugh score and MELD score every 6 months along with labs |
Fatigue, pruritus, yellowing of skin or eyes, n/v, increased abdomen size, gynecomastia, hypogonadism |
HCC screening (q6 months) |
Physical Exam |
Complications |
Jaundice, telangiectasia, caput medusae, palmar erythema, hepatomegaly, splenomegaly, ascites, asterixis |
Portal HTN, ascites, spontaneous bacterial peritonitis, oesophageal variceal haemorrhage, coagulopathy, hepatic encephalopathy, hepatorenal syndrome, hepatopulmonary syndrome, HCC, portal vein thrombosis |
Labs |
Treatment |
CBC, LFTs, alk phos, ammonia, PT/INR, albumin |
Treat underlying condition, avoid hepatotoxic substances (EtOH, NSAIDs), routine vaccines |
Imaging |
Non-selective beta blockers (propranolol) to lower portal HTN and prevent variceal bleeding |
US, CT scan |
Spironolactone and furosemide for ascites and oedema |
Aetiology is extensive: alcohol use, medications, aflatoxin, hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, parasitic infections, non-alcoholic steatohepatitis, haemochromatosis, Wilson disease, alpha-1 antitrypsin deficiency, glycogen storage disease, CF, Budd-Chiari syndrome
|
Created By
Metadata
Comments
No comments yet. Add yours below!
Add a Comment
Related Cheat Sheets